Mazza, M. G., Palladini, M., Poletti, S., & Benedetti, F. (2022). Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment. CNS drugs, 36(7), 681-702. https://doi.org/10.1007/s40263-022-00931-3
Chicago Style (17th ed.) CitationMazza, Mario Gennaro, Mariagrazia Palladini, Sara Poletti, and Francesco Benedetti. "Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment." CNS Drugs 36, no. 7 (2022): 681-702. https://doi.org/10.1007/s40263-022-00931-3.
MLA (9th ed.) CitationMazza, Mario Gennaro, et al. "Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment." CNS Drugs, vol. 36, no. 7, 2022, pp. 681-702, https://doi.org/10.1007/s40263-022-00931-3.